Feb 21 (Reuters) - IRLAB Therapeutics AB IRLABa.ST :
* ANNOUNCED ON MONDAY THAT CEO RICHARD GODFREY IS LEAVING
HIS
POSITION
* BOD HAS APPOINTED GUNNAR OLSSON, CURRENT CHAIRMAN, AS
INTERIM
CEO
* GUNNAR OLSSON WILL NOW TRANSITION TO POSITION AS BOARD
DIRECTOR
* BOD HAS APPOINTED CO'S CURRENT VICE CHAIRMAN, CAROLA
LEMNE, AS
ITS NEW CHAIRMAN
* ALL CHANGES WILL BE IMPLEMENTED IMMEDIATELY, PROCESS TO
RECRUIT
PERMANENT CEO WILL START IMMEDIATELY
Source text for Eikon: urn:newsml:reuters.com:*:nACS6LyVka
Further company coverage: IRLABa.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))